Veeva Systems Inc.
Veeva Systems Provides Preliminary Q3 2025 Financial Guidance
Summary
Veeva Systems Inc. presented its 2024 Investor Day on November 7, 2024, and provided preliminary guidance for its anticipated financial metrics for the third quarter of fiscal year 2025. During the Investor Day, the Company's Chief Financial Officer, Brian Van Wagener, stated that the Company expects to report third quarter results at or above the previously announced guidance, which was provided on August 28, 2024. The specific guidance includes total revenue of $682-685 million, subscription revenue of approximately $571 million, services revenue of $111-114 million, non-GAAP operating income of $273-275 million, and non-GAAP fully diluted net income per share of $1.57-1.58. A slide with the guidance details is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Profitelligence Alerts
Get alerts for VEEV
Be first to know when Veeva Systems Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Veeva Systems Inc.
Veeva Systems Inc. is a cloud-based software solutions provider focusing specifically on the life sciences industry. Its primary function is to develop and deliver specialized software tailored for companies in the pharmaceutical, biotechnology, and medical device sectors. Veeva's product suite includes applications for customer relationship management, content management, collaboration, and data analytics, facilitating enhanced operational efficiency and regulatory compliance. The company’s offerings are designed to optimize the critical aspects of a life sciences company's operations, such as clinical data management, regulatory submissions, and commercial activities. Veeva Systems plays a significant role in the growing digital transformation of the health-related industries, bridging the gap between advanced technological solutions and industry-specific requirements. Founded in 2007 and headquartered in Pleasanton, California, Veeva has established itself as a leader in its niche market, empowering its clients with innovative tools that streamline R&D processes and enhance their go-to-market capabilities.
Official SEC Documents
Advertisement